HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Canakinumab induces remission in a patient with resistant familial Mediterranean fever.

AuthorsDuygu Ovunc Hacihamdioglu, Seza Ozen
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 51 Issue 6 Pg. 1041 (Jun 2012) ISSN: 1462-0332 [Electronic] England
PMID22403182 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-1beta
  • canakinumab
  • C-Reactive Protein
Topics
  • Adolescent
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • C-Reactive Protein (metabolism)
  • Drug Resistance
  • Familial Mediterranean Fever (drug therapy)
  • Female
  • Humans
  • Interleukin-1beta (antagonists & inhibitors)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: